Formation Bio

Advertisement

cGxPJobs Banner

Formation Bio Launches $600M Fund to Advance Drug Development

New York, New York, United States, October 30, 2026 Formation Bio, an AI-native pharmaceutical company, has announced the launch...

By cGxPwire Editor
October 31, 2026

Read More

Formation Bio Doses First Participant in Phase 1 Trial of BLKR201, a CNS-Penetrant TYK2 Inhibitor

NEW YORK, June 9, 2026 Formation Bio announced the first participant has been dosed in a Phase 1 first-in-human...

By cGxPwire Editor
June 11, 2026

Read More

Advertisement

cGxPJobs

Directory